<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Endocrinology, Diabetes &amp; Internal Medic</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/69B28B24-560A-483F-9FC8-3D8C9D7DCAFD"><gtr:id>69B28B24-560A-483F-9FC8-3D8C9D7DCAFD</gtr:id><gtr:firstName>V Krishna K</gtr:firstName><gtr:surname>Chatterjee</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701532"><gtr:id>A8154060-EBB8-46A5-82C7-F5C33C106A53</gtr:id><gtr:title>Developing the WTCRF in Cambridge: Magnetic Resonance Spectroscopy and a Nutrition Resource &amp;amp; Appetite Laboratory</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701532</gtr:grantReference><gtr:abstractText>A Wellcome Trust-funded Clinical Research Facility (WTCRF) in Cambridge has been in
operation for several years at a high level (75%) of occupancy. Over 200 projects have been
undertaken, ranging from experimental medicine (where intensive patient investigation leads to
understanding of disease mechanisms) to trials of treatment. Obesity, Diabetes and Insulin
Resistance are epidemic worldwide and internationally-recognised research programs in
Cambridge investigate genetic forms of obesity and insulin resistance, population diabetes,
diabetes in childhood, critical illness &amp;amp; metabolism and metabolic storage diseases. Uniquely,
our WTCRF contains specialised technologies (e.g.energy expenditure measurement) that are
vital for such research and is also the locus for treatment trials (e.g replacement of leptin (an
appetite hormone) in obesity or enzymes in storage diseases; prevention of diabetes).
Magnetic resonance spectroscopy (MRS), technology which allows substances and metabolic
pathways in tissues to be measured non-invasively and non-radioactively, has significantly
advanced knowledge of metabolic disorders including diabetes. Support for an MRS scanner
together with specialist support staff, located within an expanded,existing imaging facility, will
add significantly to our metabolic research programs,with MRS measurements discovering
disease mechanisms &amp;amp; monitoring treatment response in trials. Energy (food) intake is an
important variable in both specialised (e.g. obesity) or general clinical research, and existing
CRF technologies for measuring this are rudimentary. Addition of a CRF Nutrition Resource
(staff, diet kitchen) will enable dietary intake of research subjects to be either standardised or
altered in a defined way. An ?appetite laboratory?, or mobile apparatus to measure
characteristics of eating behaviour, is essential for research of obesity and other appetitedisordered
states.</gtr:abstractText><gtr:technicalSummary>Develop current Cambridge WTCRF with technology to enhance metabolic research: 1) 3T MRI scanner with supporting staff dedicated to human MRS located within planned extension to Wolfson Brain Imaging Centre (WBIC). 2) Staff and equipment to develop Nutrition resource &amp;amp; appetite laboratory within CRF.

Enhance existing metabolic programme, which includes genetics of obesity &amp;amp; severe insulin resistance, population studies in diabetes &amp;amp; obesity, childhood insulin resistance, metabolic complications of critical illness, nuclear hormone receptor disorders &amp;amp; metabolic storage diseases. Access to a dedicated scanner will significantly augment existing metabolic research by enabling measurement of biochemical intermediates &amp;amp; metabolic pathway activity in tissues. Nutrition resource for: a) specialised test meal provision for genetic and aquired obesity research. b) control and manipulatation of calorimeter studies of energy expenditure. c) standardization or manipulation of dietry/nutritional variables in other and general CRF research protocols.</gtr:technicalSummary><gtr:fund><gtr:end>2012-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>256920</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ACRC Newsletter with MRS feature</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8DF77433-6806-4697-BA0D-E958489C5A0F</gtr:id><gtr:impact>We advertised the MRS facility in a newsletter associated with our Clinical Research Facility

This enabled local investigators to become aware of this new investigation. In addition, it enhanced recruitment of healthy volunteers to MRS studies.</gtr:impact><gtr:outcomeId>pGyq7K4SsHx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Siemens News Release - University of Cambridge installs MAGNETOM Verio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>59B2FE83-736E-4306-8DBA-0F67860344AB</gtr:id><gtr:impact>A press release was issued jointly by Siemens and the Wolfson Brain Imaging Centre (University of Cambridge) to advertise installation of 3T MRI to undertake spectroscopy funded by the Clinical Research Infrastructure Initiative

Has facilitated interaction with other spectroscopy groups</gtr:impact><gtr:outcomeId>qoBD7nPKXkK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Clinical Fellowship</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>Ocera Therapeutics</gtr:fundingOrg><gtr:id>AA24D16D-12CE-4698-B62A-3470E6CEBAA3</gtr:id><gtr:outcomeId>mmR6g5G1dcN0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator Award</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>095564/Z/11/Z</gtr:fundingRef><gtr:id>0FFB9464-B5FF-4B29-BA40-C78209B3D6AF</gtr:id><gtr:outcomeId>jLU5vd4rRnf</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A collaboration agreement between University of Cambridge and Siemens protects IPR related to mutual development of spectroscopy protocols</gtr:description><gtr:grantRef>G0701532</gtr:grantRef><gtr:id>FAB7236B-E759-44A6-B192-5AE131A3A21C</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>ez1dniP91c2</gtr:outcomeId><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>Spectroscopy protocols</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Saturation transfer techniques, selective inversion recovery, to measure in-vivo the rate of interconversion of ADP and ATP in muscle and liver and the development of adiabatic half passage excitiation pulses for use with surface coils</gtr:description><gtr:id>879EECEA-632E-4C7E-8ABE-D5D77C97CB84</gtr:id><gtr:impact>This protocol will allow us to measure ATP levels in tissues</gtr:impact><gtr:outcomeId>kGB9fSZCGiB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>31P NMR techniques to use in metabolic studies</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of localised and non-localised 13C acquisition techniques with optimised proton decoupling, to enable the measurement of 13C fats and their associated timecourse in liver and muscle following an ingested 13C labeled mixed meal.</gtr:description><gtr:id>8D8A33D0-6214-4111-BA1F-920A9FCAE628</gtr:id><gtr:impact>This will enable measurement of lipid storage and metabolism</gtr:impact><gtr:outcomeId>g9R6JgaSqV8</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>13C NMR techniques to use in metabolic studies</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>07E904CB-026F-4349-8E99-86B5875DC6B7</gtr:id><gtr:title>Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fc831db4279e6e82fa37e043232077d"><gtr:id>5fc831db4279e6e82fa37e043232077d</gtr:id><gtr:otherNames>Payne F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56def369bda228.19418482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB1850CA-57F6-4AE4-AE21-D2958B761489</gtr:id><gtr:title>Ultrasound measurements of visceral and subcutaneous abdominal thickness to predict abdominal adiposity among older men and women.</gtr:title><gtr:parentPublicationTitle>Obesity (Silver Spring, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/225341149c9120f6e377560d6b2d2f52"><gtr:id>225341149c9120f6e377560d6b2d2f52</gtr:id><gtr:otherNames>De Lucia Rolfe E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1930-7381</gtr:issn><gtr:outcomeId>PG7oaaBBS82</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7F7D55F-FC89-4CAE-85E5-61119426CDFC</gtr:id><gtr:title>Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/680a48ecbe7717257217c97eb2cbd187"><gtr:id>680a48ecbe7717257217c97eb2cbd187</gtr:id><gtr:otherNames>Semple RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>pm7MjnP3cCF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18EC580B-AE58-4213-BCD1-5BA0C1C8F366</gtr:id><gtr:title>31P magnetization transfer measurements of Pi?ATP flux in exercising human muscle.</gtr:title><gtr:parentPublicationTitle>Journal of applied physiology (Bethesda, Md. : 1985)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a19c6d099cf1b25787156cbb8ba4b5f"><gtr:id>9a19c6d099cf1b25787156cbb8ba4b5f</gtr:id><gtr:otherNames>Sleigh A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0161-7567</gtr:issn><gtr:outcomeId>56dec2e2bb9e09.89146182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A8CD87-BEC1-4955-9DD2-78F9ACDE2DB4</gtr:id><gtr:title>Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e796ef66981b78a20088d051968ed2a"><gtr:id>0e796ef66981b78a20088d051968ed2a</gtr:id><gtr:otherNames>Gradmark AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn><gtr:outcomeId>eq5Xg3XNZbR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1120760-B69A-47A2-85F0-FFE14B0E2F2B</gtr:id><gtr:title>Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ad7bbb31e2eb6dd1167bab63e3f44ff"><gtr:id>4ad7bbb31e2eb6dd1167bab63e3f44ff</gtr:id><gtr:otherNames>Thankamony A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>56ded9aee9b490.53435643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79107B80-275E-4950-B645-693728E95496</gtr:id><gtr:title>Lipodystrophy: metabolic insights from a rare disorder.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120893d6db842ae2fac96265727b0fb4"><gtr:id>120893d6db842ae2fac96265727b0fb4</gtr:id><gtr:otherNames>Huang-Doran I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>n2VoKd11vgT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9ED6A228-C6D0-4C50-8AA9-8EF502260E8D</gtr:id><gtr:title>Validation of ultrasound estimates of visceral fat in black South African adolescents.</gtr:title><gtr:parentPublicationTitle>Obesity (Silver Spring, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/225341149c9120f6e377560d6b2d2f52"><gtr:id>225341149c9120f6e377560d6b2d2f52</gtr:id><gtr:otherNames>De Lucia Rolfe E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1930-7381</gtr:issn><gtr:outcomeId>ceRvt92YuBX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B980A7B9-52BB-4AE5-92A6-88B88978CC70</gtr:id><gtr:title>Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals.</gtr:title><gtr:parentPublicationTitle>Diabetology &amp; metabolic syndrome</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/245d71433e71796c260ffd1810e38fe7"><gtr:id>245d71433e71796c260ffd1810e38fe7</gtr:id><gtr:otherNames>Finucane FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1758-5996</gtr:issn><gtr:outcomeId>56def369e4c073.85410488</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F79DAEDA-69F0-48A8-B043-3E0917912258</gtr:id><gtr:title>Defective mitochondrial function in vivo in skeletal muscle in adults with Down's syndrome: a 31P-MRS study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d9adf8002c75bb1cef4e5bf9579ce2c"><gtr:id>2d9adf8002c75bb1cef4e5bf9579ce2c</gtr:id><gtr:otherNames>Phillips AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>SAeWjjDbAMV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ECD525D-AEA4-4752-B2C6-E66233E64C84</gtr:id><gtr:title>Use of diffusion tensor imaging to assess the impact of normobaric hyperoxia within at-risk pericontusional tissue after traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55ec626a79cd750f69f4f8b03fd12df8"><gtr:id>55ec626a79cd750f69f4f8b03fd12df8</gtr:id><gtr:otherNames>Veenith TV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>546350563511e8.43877137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49BE2D01-4AC7-4122-9E29-BD413CDD43BC</gtr:id><gtr:title>Low circulating levels of IGF-1 in healthy adults are associated with reduced ?-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ad7bbb31e2eb6dd1167bab63e3f44ff"><gtr:id>4ad7bbb31e2eb6dd1167bab63e3f44ff</gtr:id><gtr:otherNames>Thankamony A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>546350565e3538.60772766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1870E2FD-AC86-4BDA-8796-8853F4BE7CDA</gtr:id><gtr:title>Mitochondrial dysfunction in patients with primary congenital insulin resistance.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a19c6d099cf1b25787156cbb8ba4b5f"><gtr:id>9a19c6d099cf1b25787156cbb8ba4b5f</gtr:id><gtr:otherNames>Sleigh A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>Jgp8PPxNQod</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E1A03B7-AAFE-46ED-B292-1B228B489D9B</gtr:id><gtr:title>Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad64693a8580f84d8f068e7d887e1451"><gtr:id>ad64693a8580f84d8f068e7d887e1451</gtr:id><gtr:otherNames>Challis BG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>56ded9af59b937.76519940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23218896-E3D3-47E5-AE50-269E6DAD66B8</gtr:id><gtr:title>Randomized controlled trial of the efficacy of aerobic exercise in reducing metabolic risk in healthy older people: The Hertfordshire Physical Activity Trial.</gtr:title><gtr:parentPublicationTitle>BMC endocrine disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/245d71433e71796c260ffd1810e38fe7"><gtr:id>245d71433e71796c260ffd1810e38fe7</gtr:id><gtr:otherNames>Finucane FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1472-6823</gtr:issn><gtr:outcomeId>jy23chwnPKY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54BC81CB-39B5-4352-AC5F-39B9C5B89D35</gtr:id><gtr:title>Simple and effective exercise design for assessing in vivo mitochondrial function in clinical applications using (31)P magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a19c6d099cf1b25787156cbb8ba4b5f"><gtr:id>9a19c6d099cf1b25787156cbb8ba4b5f</gtr:id><gtr:otherNames>Sleigh A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56dec29a11df13.88802170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE05BC25-CAC0-44B5-A8A6-1B2F4678F348</gtr:id><gtr:title>The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/245d71433e71796c260ffd1810e38fe7"><gtr:id>245d71433e71796c260ffd1810e38fe7</gtr:id><gtr:otherNames>Finucane FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>Raz4ujLyaXw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16F1A4CA-720E-4551-A065-C92DE68385E5</gtr:id><gtr:title>Inter subject variability and reproducibility of diffusion tensor imaging within and between different imaging sessions.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55ec626a79cd750f69f4f8b03fd12df8"><gtr:id>55ec626a79cd750f69f4f8b03fd12df8</gtr:id><gtr:otherNames>Veenith TV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546350560df920.55410061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C0BD327-D062-4909-B2BB-843A8419DE5F</gtr:id><gtr:title>Mitochondrial oxidative phosphorylation is impaired in patients with congenital lipodystrophy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a19c6d099cf1b25787156cbb8ba4b5f"><gtr:id>9a19c6d099cf1b25787156cbb8ba4b5f</gtr:id><gtr:otherNames>Sleigh A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_12617_27_22238385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFFAC829-F003-47FC-96B0-B9833FD8004B</gtr:id><gtr:title>Intramyocellular lipid levels are associated with peripheral, but not hepatic, insulin sensitivity in normal healthy subjects.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46127a47c8d55a90592bff961c49a774"><gtr:id>46127a47c8d55a90592bff961c49a774</gtr:id><gtr:otherNames>Salgin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>DcbrcaedShB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C09E43A9-FC2E-4DCA-8BC9-89F292A6F0D9</gtr:id><gtr:title>Truncation of POC1A associated with short stature and extreme insulin resistance.</gtr:title><gtr:parentPublicationTitle>Journal of molecular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dcc72a8a22c9918d417e495e2f70455"><gtr:id>4dcc72a8a22c9918d417e495e2f70455</gtr:id><gtr:otherNames>Chen JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0952-5041</gtr:issn><gtr:outcomeId>56def36a122f15.57282712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4774765-81B2-445D-ACAD-F90A589A9128</gtr:id><gtr:title>Intrahepatic Lipid Content and Insulin Resistance Are More Strongly Associated with Impaired NEFA Suppression after Oral Glucose Loading Than with Fasting NEFA Levels in Healthy Older Individuals.</gtr:title><gtr:parentPublicationTitle>International journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/245d71433e71796c260ffd1810e38fe7"><gtr:id>245d71433e71796c260ffd1810e38fe7</gtr:id><gtr:otherNames>Finucane FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1687-8337</gtr:issn><gtr:outcomeId>pm_12617_27_23737780</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701532</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>70</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>